Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles

Lignende værker

• Artificial Endometrial Preparation for Frozen-Thawed Embryo Transfer with or without Pretreatment with Depot Gonadotropin Releasing Hormone Agonist in Women with Regular Menses
  af: Azimi Nekoo, Elham, et al.
  Udgivet: (2015)
• GnRH antagonist versus agonist in normoresponders undergoing ICSI: a randomized clinical trial in Iran
  af: Tehraninejad, Ensieh, et al.
  Udgivet: (2011)
• Dexamethasone As a Supplement for Exogenous Gonadotropin to Improve Ovarian Response of Women over 35 Years Undergoing IVF/ICSI Cycles
  af: Mahnaz Ashrafi, et al.
  Udgivet: (2007-07-01)
• Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphen citrate gonadotropins in controlled ovarian hyperstimulation: a prospective, simply randomized, clinical trial
  af: Sh. Tehrani nejad, Ensieh, et al.
  Udgivet: (2008)
• Thyroid Dysfunction Associated with Administration of the Long-Acting Gonadotropin-Releasing Hormone Agonist
  af: Han, Eun Jin, et al.
  Udgivet: (2013)